-
- Inoue Kosuke
- Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan
-
- Saito Jun
- Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan
-
- Kondo Tetsuo
- Department of Human Pathology, University of Yamanashi Interdisciplinary Graduate School of Medicine and Engineering, Japan
-
- Miki Kaoru
- Departments of Endocrinology and Diabetes, JCHO Tokyo Yamate Medical Center, Japan
-
- Sugisawa Chiho
- Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan
-
- Tsurutani Yuya
- Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan
-
- Hasegawa Naoki
- Department of Pathology, Yokohama Rosai Hospital, Japan
-
- Kowase Shinya
- Department of Cardiovascular Medicine, Yokohama Rosai Hospital, Japan
-
- Kakuta Yukio
- Department of Pathology, Yokohama Rosai Hospital, Japan
-
- Omura Masao
- Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan
-
- Nishikawa Tetsuo
- Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan
この論文をさがす
説明
<p>We describe a case of amiodarone-induced thyrotoxicosis (AIT) with cardiopulmonary arrest (CPA) in a 49-year-old woman. The patient had been treated with amiodarone for non-sustained ventricular tachycardia. Two weeks prior to her admission, she developed thyrotoxicosis and prednisolone (PSL, 30 mg daily) was administered with the continuation of amiodarone. However, she was admitted to our hospital for CPA. We performed total thyroidectomy to control her thyrotoxicosis and the pathological findings were consistent with type 2 AIT. She gradually improved and was discharged on day 84. This case demonstrates the importance of considering immediate total thyroidectomy for patients with uncontrollable AIT. </p>
収録刊行物
-
- Internal Medicine
-
Internal Medicine 57 (1), 59-63, 2018
一般社団法人 日本内科学会